OBI Pharma, Inc. and Odeon Therapeutic, the biopharma companies, have entered into an exclusive license agreement whereby OBI grants rights of OBI-999, a novel...
US drugmaker Eli Lilly is scaling back business in Russia, but still pledge to continue supplying critical medicines.
Lilly said it will send medicines for...
The company Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today...
Royal Philips, a global leader in health technology, announced that Collaboration Live has received expansion of its U.S. Food & Drug Administration 510(k) market...
Merck (MSD) on Tuesday announced that it will stop the Phase 3 KEYLYNK-010 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with LYNPARZA, a...
Illumina, Inc. today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal...